Company Summary:

FL87, Inc. is a privately held, early-stage biotechnology company developing a novel DNA platform that can address currently untreatable diseases.

FL87 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ: MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.

Job Summary:

The Head of Corporate Strategy and Development will be responsible for driving the company’s strategic direction and corporate development. This role will lead high-priority, high-impact projects across the organization, partnering with scientific and business leaders to drive corporate strategy, business model innovation, pipeline strategy, market analysis, investor relations, and business development. The successful candidate will have scientific acumen, be deeply collaborative, an outstanding communicator, and will thrive in a fast-paced, entrepreneurial environment.

Key Responsibilities

Collaborate closely with the executive team and cross-functional leaders to shape and execute the company’s corporate development strategy.
Successfully translate vision and strategy into an executable plan with identified resources and timelines.
Implement business model innovations across value pools and target opportunities, uncovering paths for maximum value creation.
Analyze market trends, industry dynamics, and competitive landscapes to identify market and growth opportunities.
Establish relationships with investors, clearly communicating the company’s vision, strategy, and growth plans to build trust and buy-in.
Partner with internal stakeholders, such as the marketing and communications teams, to ensure alignment and consistency in messaging and branding.
Develop and refine company presentation materials
Foster strong cross-functional collaboration with teams such as R&D, operations, finance, and legal.
Appropriately balance multiple priorities and work against tight timelines.
Rapidly establish credibly, trust, and respect across the organization operating as a true strategic thought partner to the FL87 team.
Lead with authenticity and a sense of urgency that inspires the team to communicate openly and thrive together.

Qualifications and Skills

PhD preferred, BS or other graduate degree in life sciences required.
Passion for genetic medicine approaches.
Strong familiarity with the pharmaceutical/biotech industry and drug development landscape. Experience in Biopharma management consulting and startup Biotech highly preferred
Proven track record of building and developing strategy & executing complex projects.
Ability to communicate credibly and clearly with clinicians and key opinion leaders.
Strong attention to detail.
Capable of communicating complex ideas in simple frameworks and developing compelling presentations
Curious, sharp business acumen, superior analytic and communication skills.
Results-driven, high-performer with a highly collaborative style; able to influence and build consensus across all levels of the organization.
Highly self-motivated with demonstrated agility to multitask, manage time, handle uncertainty, and work under pressure with limited oversight.

Location: Cambridge, MA

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team! See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated. Learn more about our Company Creation Model. Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

At Flagship, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background.

Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

#LI-SO1